Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

BACKGROUND: Although breast cancer risk is greater in users of estrogen–progestin than estrogen-only formulations of menopausal hormonal therapy, reports on their effects have been somewhat inconsistent. We investigated whether the timing of these therapies affected breast cancer incidence. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Beral, Valerie, Reeves, Gillian, Bull, Diana, Green, Jane
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039726/
https://www.ncbi.nlm.nih.gov/pubmed/21278356
http://dx.doi.org/10.1093/jnci/djq527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039726/
https://www.ncbi.nlm.nih.gov/pubmed/21278356
http://dx.doi.org/10.1093/jnci/djq527

Ejemplares similares